Prostate Cancer

Top Story

High-dose radiation effective in oligometastatic prostate cancer

High-dose radiation effective in oligometastatic prostate cancer
September 18, 2019

Read the Perspective from Mark A. Hallman, MD, PhD

FDA News

FDA expands Erleada approval for prostate cancer

September 18, 2019
The FDA expanded the approval of apalutamide to include treatment of men with metastatic castration-sensitive prostate cancer. Apalutamide (Erleada, Janssen) — an…
Meeting NewsPerspective

Low PSA levels predict lack of benefit from long-term hormone therapy after prostate surgery

September 16, 2019
Long-term antiandrogen therapy did not improve OS when administered during early salvage radiation therapy among patients with recurrent prostate cancer and low PSA…
Meeting News

IASLC: All physicians should screen patients with cancer for tobacco use

September 7, 2019
BARCELONA — The International Association for the Study of Lung Cancer, or IASLC, today issued a declaration at its World Conference on Lung Cancer advising all…
More Headlines »
CME

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »
Video

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
More »
CME ABIM MOC

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
More »